United Nations Special Committee on Palestine

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV

Retrieved on:

Sonntag, November 5, 2023

Slate, Prior, Proxy, United Nations Special Committee on Palestine, Disclosure, Committee, Roivant Sciences, Skadden, Arps, Slate, Meagher & Flom, Mergers and acquisitions, Complaint, Pomerantz, LLP, Special, Sumitomo Pharma

NEW YORK, Nov. 05, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Myovant Sciences, Ltd. (“Myovant” or the “Company”) (NASDAQ: MYOV).

Key Points:

NEW YORK, Nov. 05, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Myovant Sciences, Ltd. (“Myovant” or the “Company”) (NASDAQ: MYOV).
Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.
The investigation concerns whether Myovant and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV

Retrieved on:

Freitag, Oktober 27, 2023

NEW YORK, Oct. 27, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Myovant Sciences, Ltd. (“Myovant” or the “Company”) (NASDAQ: MYOV).

Key Points:

NEW YORK, Oct. 27, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Myovant Sciences, Ltd. (“Myovant” or the “Company”) (NASDAQ: MYOV).
Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.
The investigation concerns whether Myovant and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Greenlight Capital Sends Letter to Special Committee of Vitesco Technologies Regarding Schaeffler AG Tender Offer and Merger Proposal

Retrieved on:

Montag, November 6, 2023

Greenlight Capital, Inc. (“Greenlight”), today sent the following letter to the Special Committee of the Supervisory Board of Vitesco Technologies Group AG (“Vitesco”) and Mr. Andreas Wolf, Chairman of the Executive Board and Chief Executive Officer of Vitesco, regarding Schaeffler AG’s (“Schaeffler”) proposed €91.00 per share cash tender offer for all outstanding shares of Vitesco and proposed three-step transaction to merge Vitesco into Schaeffler.

Key Points:

Greenlight Capital, Inc. (“Greenlight”), today sent the following letter to the Special Committee of the Supervisory Board of Vitesco Technologies Group AG (“Vitesco”) and Mr. Andreas Wolf, Chairman of the Executive Board and Chief Executive Officer of Vitesco, regarding Schaeffler AG’s (“Schaeffler”) proposed €91.00 per share cash tender offer for all outstanding shares of Vitesco and proposed three-step transaction to merge Vitesco into Schaeffler.
To: Special Committee of the Supervisory Board of Vitesco Technologies Group AG and Mr. Andreas Wolf, Chairman of the Executive Board (CEO)
Dear members of the Special Committee and Mr. Wolf,
Funds managed by Greenlight Capital, Inc. and its affiliates collectively hold approximately 3.5% of Vitesco Technologies Group AG (“Vitesco”) shares outstanding.
We identified Vitesco as the winner in “Electrification” post spin-off from Continental AG and we have been a supportive long-term shareholder.
Vitesco could initiate this spinoff process and aim to implement the spinoff before Schaeffler would have time to propose its undesirable share-for-share merger.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV

Retrieved on:

Donnerstag, Oktober 19, 2023

Slate, Proxy, United Nations Special Committee on Palestine, Disclosure, Committee, Roivant Sciences, Skadden, Arps, Slate, Meagher & Flom, Mergers and acquisitions, Complaint, Pomerantz, LLP, Special, Sumitomo Pharma

NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Myovant Sciences, Ltd. (“Myovant” or the “Company”) (NASDAQ: MYOV).

Key Points:

NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Myovant Sciences, Ltd. (“Myovant” or the “Company”) (NASDAQ: MYOV).
Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.
The investigation concerns whether Myovant and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

CNSL Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of Consolidated Communications Holdings, Inc.

Retrieved on:

Mittwoch, Oktober 18, 2023

Sale, CNSL, Searchlight Capital, United Nations Special Committee on Palestine, Committee, BCI, Iron Eagle, Crown corporations of Canada, Wohl, Alpha, Security (finance)

MONSEY, N.Y., Oct. 18, 2023 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Consolidated Communications Holdings, Inc. (Nasdaq: CNSL) (“CNSL”) to Searchlight Capital Partners, L.P. (“Searchlight”) and British Columbia Investment Management Corporation (“BCI”) for $4.70 per share in cash.

Key Points:

MONSEY, N.Y., Oct. 18, 2023 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Consolidated Communications Holdings, Inc. (Nasdaq: CNSL) (“CNSL”) to Searchlight Capital Partners, L.P. (“Searchlight”) and British Columbia Investment Management Corporation (“BCI”) for $4.70 per share in cash.
On October 16, 2023, CNSL announced that it had agreed to be sold to Searchlight and BCI for $4.70 per share in cash.
The proposed sale was approved by a special committee of purportedly independent and disinterested directors of the Board of Directors (“Special Committee”) formed to evaluate and consider the proposal and other potential strategic alternatives.
“We are investigating whether the CNSL Board of Directors acted in the best interests of CNSL shareholders in approving the sale,” explained Joshua Fruchter, a founding partner of Wohl & Fruchter.

EngageSmart Agrees to Be Acquired by Vista Equity Partners for $4.0 Billion

Retrieved on:

Montag, Oktober 23, 2023

Under the terms of the agreement, EngageSmart stockholders will receive $23.00 per share in cash upon completion of the proposed transaction.

Key Points:

Under the terms of the agreement, EngageSmart stockholders will receive $23.00 per share in cash upon completion of the proposed transaction.
“We have built an amazing business by putting our customers at the center of everything we do,” said Bob Bennett, EngageSmart CEO.
Vista intends to finance the transaction with fully committed equity financing that is not subject to a financing condition.
Kirkland & Ellis LLP is acting as legal counsel to Vista Equity Partners.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV

Retrieved on:

Mittwoch, Oktober 11, 2023

Slate, Pomerantz, LLP, Disclosure, Skadden, Arps, Slate, Meagher & Flom, Prior, Sumitomo Pharma, Roivant Sciences, Proxy, Complaint, Mergers and acquisitions, United Nations Special Committee on Palestine, Committee, Special

NEW YORK, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Myovant Sciences, Ltd. (“Myovant” or the “Company”) (NASDAQ: MYOV).

Key Points:

NEW YORK, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Myovant Sciences, Ltd. (“Myovant” or the “Company”) (NASDAQ: MYOV).
Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.
The investigation concerns whether Myovant and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV

Retrieved on:

Dienstag, Oktober 3, 2023

Slate, LLP, Prior, Sumitomo Pharma, Committee, Disclosure, Special, Proxy, Mergers and acquisitions, Skadden, Arps, Slate, Meagher & Flom, Roivant Sciences, Complaint, United Nations Special Committee on Palestine, Pomerantz

NEW YORK, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Myovant Sciences, Ltd. (“Myovant” or the “Company”) (NASDAQ: MYOV).

Key Points:

NEW YORK, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Myovant Sciences, Ltd. (“Myovant” or the “Company”) (NASDAQ: MYOV).
Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.
The investigation concerns whether Myovant and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOV

Retrieved on:

Dienstag, September 26, 2023

NEW YORK, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Myovant Sciences, Ltd. (“Myovant” or the “Company”) (NASDAQ: MYOV).

Key Points:

NEW YORK, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Myovant Sciences, Ltd. (“Myovant” or the “Company”) (NASDAQ: MYOV).
Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.
The investigation concerns whether Myovant and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Pipestone Announces That ISS and Glass Lewis Recommend Shareholders Vote “for” Proposed Combination With Strathcona to Create a Leading Canadian Energy Producer, and Sets Record Straight on Flawed and Misleading Arguments by GMT

Retrieved on:

Montag, September 18, 2023

Pipestone also wishes to set the record straight on the flawed assumptions and misleading arguments made by Atlanta, Georgia-based GMT Capital Corp. (“GMT”) against this value-creating transaction.

Key Points:

Pipestone also wishes to set the record straight on the flawed assumptions and misleading arguments made by Atlanta, Georgia-based GMT Capital Corp. (“GMT”) against this value-creating transaction.
It was clear to the independent and unconflicted members of the Special Committee that the Strathcona proposal was in the best interests of the Shareholders.
The recommendations that Shareholders vote “FOR” the Arrangement by the independent proxy advisory firms ISS and Glass Lewis underscore the Board’s recommendation.
The Board of Pipestone has approved the Arrangement and recommends that Shareholders vote FOR the Arrangement at the Meeting.